PMID: 22913258
Title: HIV epidemic in Asia optimizing and expanding vaccine development
Abstract: The recent evidence in Thailand for protection from acquisition of HIV through vaccination in a mostly heterosexual population has generated considerable hope. Building upon these results and the analysis of the correlates of risk remains among the highest priorities. Improved vaccine concepts including heterologous prime-boost regimens, improved proteins with potent adjuvants and new vectors expressing mosaic antigens may soon enter clinical development to assess vaccine efficacy in men who have sex with men. Identifying heterosexual populations with sufficient HIV incidence for the conduct of efficacy trials represents perhaps the main challenge in Asia. Fostering translational research efforts in Asian countries may benefit from the development of master strategic plans and program management processes.
Date: 1970-08-21
Year: 2012
Journal: Expert Rev Vaccines
PMID Author: Nitayaphan S, Ngauy V, O'Connell R, Excler JL
HIV epidemic in Asia: optimizing and expanding vaccine development. Expert Rev Vaccines 2012;11(7):805-19 doi: 10.1586/erv.12.49

Media Contacts

Africa

Ethel Makila
+254 71 904 3142
EMakila@iavi.org

 

Europe

Hester Kuipers
+31 20 521 0343
HKuipers@iavi.org 

 

India

Saif ul Hadi
+91 11 4737 6032
SulHadi@iavi.org 

 

United States

Rose Catlos
+1 212 847 1049
RCatlos@iavi.org